Obesema 0.5mg Injection

Obesema 0.5 mg Injection – Semaglutide for Weight Management

Obesema 0.5 mg Injection is a prescription pre-filled injection pen containing Semaglutide 0.5 mg per dose. It is used with a reduced-calorie diet and regular physical activity to support long-term weight management in eligible adults. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It acts on areas involved in appetite regulation, helping reduce hunger, increase feelings of fullness, and support reduced calorie intake. Each multidose disposable pen provides four doses of 0.5 mg for once-weekly administration. The 0.5 mg strength is generally used after an initial lower-dose treatment period and should be started only according to the prescribing healthcare professional’s dose-escalation plan.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 0.5 mg Per Dose: Each prescribed injection delivers 0.5 mg of semaglutide.
• Four-Dose Pen: Each multidose disposable pen provides four weekly doses.
• Supports Weight Management: Helps regulate appetite and reduce calorie intake.
• Once-Weekly Administration: Designed for use on the same day each week.
• Subcutaneous Injection: Administered under the skin of the abdomen, thigh, or upper arm.
• Prescription Medicine: Must be used as part of a medically supervised treatment programme.

Active Ingredient

• Semaglutide 0.5 mg per dose: A GLP-1 receptor agonist that helps regulate appetite, increase fullness, and reduce food intake.

Uses

• Long-term weight management in eligible adults with obesity.
• Weight management in eligible overweight adults who have at least one weight-related health condition.
• Weight-loss maintenance when combined with a reduced-calorie diet and increased physical activity.
• Reduction of cardiovascular risk in selected adults with established cardiovascular disease and obesity or overweight, when specifically prescribed.

How to Use

• Use Obesema 0.5 mg Injection exactly as prescribed by your healthcare professional.
• Inject the prescribed dose once weekly on the same day each week.
• It may generally be administered at any time of day, with or without food.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with each weekly dose.
• Use a new compatible needle for every injection.

Precautions

• Obesema 0.5 mg is generally a dose-escalation strength and is not normally the first treatment dose.
• Nausea, vomiting, and diarrhoea may cause dehydration. Maintain adequate fluid intake unless medically restricted.
• The risk of low blood sugar may increase when semaglutide is used with insulin or sulfonylurea medicines.
• People with diabetes should report sudden or worsening changes in vision.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or heartburn.
• Abdominal bloating or increased gas.
• Headache.
• Dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with certain diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Store the unused pen in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen away from the refrigerator’s cooling element.
• Keep the pen in its original packaging to protect it from light.
• Do not store the pen with a needle attached.
• Follow the original Obesema pack instructions for storage after first use and the permitted in-use period.
• Do not use if the solution appears cloudy, coloured, or contains visible particles.
• Do not use if the pen, seal, or packaging is damaged or tampered with.
• Keep out of the sight and reach of children.

Legal Disclaimer: Obesema 0.5 mg Injection is a prescription semaglutide medicine intended for use under the supervision of a qualified healthcare professional. The prescribing doctor must determine eligibility, dose escalation, treatment duration, and continued use. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the original instructions supplied with the medicine.